T1	Participants 22 51	children with acute leukemia.
T2	Participants 87 238	One hundred four children with advanced leukemia in relapse (74 with acute lymphocytic leukemia [ALL] and 30 with acute nonlymphocytic leukemia [ANLL])
T3	Participants 839 886	Fatal cardiac toxicity occurred in one patient.
